Biomarkers-based personalized follow-up in chronic heart failure improves patient’s outcomes and reduces care associate cost
Abstract Background Heart failure (HF) is a major and growing medical and economic problem, with high prevalence and incidence rates worldwide. Cardiac Biomarker is emerging as a novel tool for improving management of patients with HF with a reduced left ventricular ejection fraction (HFrEF). Method...
Main Authors: | Antonio Leon-Justel, Jose I. Morgado Garcia-Polavieja, Ana Isabel Alvarez-Rios, Francisco Jose Caro Fernandez, Pedro Agustin Pajaro Merino, Elena Galvez Rios, Ignacio Vazquez-Rico, Jose Francisco Diaz Fernandez |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-05-01
|
Series: | Health and Quality of Life Outcomes |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12955-021-01779-9 |
Similar Items
-
Patient Flows, Patient Distribution Computations and Medicines Accounting in the Pharmacoeconomic Models Through Procurement Perspective
by: Yagudina R, et al.
Published: (2021-07-01) -
Cost-Effectiveness and Budget Impact of Comprehensive Anemia Management, The First Pillar of Patient Blood Management, on the Turkish Healthcare System
by: Tatar M, et al.
Published: (2022-05-01) -
Patients as research partners in preference studies: learnings from IMI-PREFER
by: Meredith Y. Smith, et al.
Published: (2023-04-01) -
How to engage patient partners in health service research: a scoping review protocol
by: Sarah Cecilie Tscherning, et al.
Published: (2021-04-01) -
Patient involvement in cardiovascular research: a qualitative impact evaluation
by: Eva Vroonland, et al.
Published: (2019-10-01)